Skip to content

A study on the effect of compound supplement on body fat and exhalation metabolism -A Randomized, Double-blind, Placebo-controlled, Parallel Study-

A study on the effect of compound supplement on body fat and exhalation metabolism -A Randomized, Double-blind, Placebo-controlled, Parallel Study- - A study on the effect of compound supplement on body fat and exhalation metabolism

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027077
Enrollment
54
Registered
2018-09-01
Start date
2017-04-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Study food1 12weeks Study food2 12weeks Placebo 12weeks

Sponsors

Miura Clinic, Medical Corporation Kanonkai
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)20<=Age<=59 of healthy males and females (2)23<=BMI<30

Exclusion criteria

Exclusion criteria: (1)Under treatment and/or have medical history of diabetes, liver disease, renal disease, gastrointestinal disease, peripheral vascular disease and/or other serious disease (2)Subjects who may be allergic reaction to any component of the test foods (3)Cardiopulmonary impairment (4)Hepatic impairment and/or renal impairment (5)Medical history of gastrointestinal surgery (6)Subjects who are under treatment (7)Having allergy to some foods and/or some drugs (8)Exercising intensely and/or on a diet (9)The weight is easy to fluctuate and/or the weight fluctuates more than plus or minus 2kg as compared with one month ago when the study begins (10)Taking functional foods, supplements and/or drugs that might affect the study (11)Heavy drinker and/or cannot stop drinking each measurement day and its previous day (12)Women who are pregnant, may become pregnant and/or nursing mothers (13)Participating subject of other clinical study and/or having a plan during this study period (14)Judged as unsuitable for the study by the investigator

Design outcomes

Primary

MeasureTime frame
Visceral fat area, Subcutaneous fat area, Total fat area, Waist circumference, Hip circumference,Exhalation data

Secondary

MeasureTime frame
Blood biochemistry, Body weight, Body mass index

Countries

Japan

Contacts

Public ContactYuko Takahashi

HABA Laboratories,Inc. Life Science Research Institute Analysis Center

y_takahashi@haba.co.jp03-5296-8724

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026